Literature DB >> 15146192

Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness.

Brenda K Eustace1, Takashi Sakurai, Jean K Stewart, Dean Yimlamai, Christine Unger, Carol Zehetmeier, Blanca Lain, Claudia Torella, Stefan W Henning, Gerald Beste, Bradley T Scroggins, Len Neckers, Leodevico L Ilag, Daniel G Jay.   

Abstract

Tumour cell invasiveness is crucial for cancer metastasis and is not yet understood. Here we describe two functional screens for proteins required for the invasion of fibrosarcoma cells that identified the molecular chaperone heat shock protein 90 (hsp90). The hsp90 alpha isoform, but not hsp90 beta, is expressed extracellularly where it interacts with the matrix metalloproteinase 2 (MMP2). Inhibition of extracellular hsp90 alpha decreases both MMP2 activity and invasiveness. This role for extracellular hsp90 alpha in MMP2 activation indicates that cell-impermeant anti-hsp90 drugs might decrease invasiveness without the concerns inherent in inhibiting intracellular hsp90.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146192     DOI: 10.1038/ncb1131

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  198 in total

1.  A chemical cross-linking method for the analysis of binding partners of heat shock protein-90 in intact cells.

Authors:  Shaoming Song; Sutapa Kole; Michel Bernier
Journal:  Biotechniques       Date:  2012-04       Impact factor: 1.993

2.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

Review 3.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

4.  Identification of heat shock protein 90α as an IMH-2 epitope-associated protein and correlation of its mRNA overexpression with colorectal cancer metastasis and poor prognosis.

Authors:  Wei-Shone Chen; Chun-Chung Lee; Yuan-Ming Hsu; Chia-Chi Chen; Tze-Sing Huang
Journal:  Int J Colorectal Dis       Date:  2011-04-26       Impact factor: 2.571

Review 5.  Quality control of protein folding in extracellular space.

Authors:  Justin J Yerbury; Elise M Stewart; Amy R Wyatt; Mark R Wilson
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

6.  The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion.

Authors:  Ellinor Oxelmark; Jennifer M Roth; Peter C Brooks; Steven E Braunstein; Robert J Schneider; Michael J Garabedian
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

7.  S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities.

Authors:  Antonio Martínez-Ruiz; Laura Villanueva; Cecilia González de Orduña; Daniel López-Ferrer; María Angeles Higueras; Carlos Tarín; Ignacio Rodríguez-Crespo; Jesús Vázquez; Santiago Lamas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

Review 8.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

9.  Differential heat shock protein localization in chronic lymphocytic leukemia.

Authors:  Nina C Dempsey; Francesca Leoni; H Elyse Ireland; Christine Hoyle; John H H Williams
Journal:  J Leukoc Biol       Date:  2009-12-10       Impact factor: 4.962

Review 10.  Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket.

Authors:  Alison Donnelly; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.